Search Results for "immutable x"
Harvard Blockchain Lab Applauds Fight to Fame Model for True Realization of Decentralized Ecosystem
Fight to Fame, a blockchain-based entertainment platform, has been praised by the Harvard Blockchain Lab for consistently presenting decentralized events, online malls, movies, and action star reality shows. It uses a BMS business model in the production of action movies, and fans are empowered by the FF Token when voting and making purchases.
China, the PBoC x Blockchain: Love and Marriage, Horse and Carriage
It’s all about China and blockchain. After breaking news of President Xi Jinping’s official endorsement on the blockchain technology and Bitcoin performing a sharp “to-the-moon” move and hitting $10K over the weekend, blockchain-related stocks in China also received a major boost.
HashCash Consultants to Streamline Drug Research and Clinical Trials with Blockchain
HashCash Consultants, a US-based blockchain development company, has set its eyes on revamping the complex process of clinical trials and drug research by availing blockchain solutions. It intends to realize this by forming a pharma consortium with pharmaceutical firms and other medical players.
Google Integrates Blockchain Technology to Root Out Fraudulent Actors
Google claimed that they started integrating blockchain technology into their exchange is security theater, since they would essentially write themselves out of the deal between advertisers and publishers if Google were to create an immutable, open, distributed public ledger for its exchange.
Blockchain-Powered Cross-Border B2B Transactions to Surpass $4.4 Trillion by 2024
According to Juniper Research, blockchain-enabled B2B cross-border payments will be more than $4.4 trillion by 2024. This will be a substantial rise from the current $171 billion.
VanEck, SolidX to Sell ‘Limited’ Bitcoin ETF to Institutions
VanEck and Solid X revealed that they have a workaround to bypass regulatory issues and are using an SEC exemption that will allow their product to be offered to institutions such as hedge funds and banks, but not to retail investors.